| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |